PHUSE Archive
All materials from PHUSE Events (e.g. Connect conferences, SDEs) can be found below. Using the filters will allow you to narrow down your search of our vast archive. In the interest of sharing knowledge, this section is open to everyone.
Please reach out to communications@phuse.global if you require further assistance finding what you need.
Show/hide columns
| Event | Year | Region | City | Title | Author | Company | Co-author | Keywords | Links |
|---|---|---|---|---|---|---|---|---|---|
Webinar | 2025 | Worldwide | Virtual | January Webinar Wednesday | WW | REC_WW01.mp4 | |||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Day 1 Winter Data Transparency Event 2025 | N/A | REC_DT01.mp4 | |||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Improve data quality and explanability based on quantitative and qualitative assessments of re-identification risks. | Louis Philippe Sondeck | Clever Identity | PRE_DT01.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Reducing Regulatory Uncertainty Around Anonymization: Perspectives of Canadian Privacy Regulators. | Lisa Pilgrim | University of Ottawa | PRE_DT02.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Data Anonymisation Techniques and Experiences. | Anju Bhatia | Novo Nordisk | Swetha Ram | PRE_DT03.pdf | |
Data Transparency | 2025 | EU | Virtual – Winter Meeting | The Emperor's New Clothes: Unveiling the Risks of Anonymization in Clinical Trial Data. | Lora Killian | Pfizer | PRE_DT04.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Day 2 Winter Data Transparency Event 2025 | N/A | REC_DT02.mp4 | |||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Clinical Trial Results at CTIS: Analysis of Compliance with Annex IV of EU CTR 536/2014. | Shalini Dwivedi | Krystelis | PRE_DT05.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Collaborative AI Networks for Global Clinical Trial Transparency Operations. | Woo Song | Xogene | PRE_DT06.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Strategies for Enhancing the Accessibility of ClinicalTrials.gov. | Samantha Toscano | Biogen | Megan Larkin | PRE_DT07.pdf | |
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Considerations for Using AI to Create Lay Summaries of Trial Results | Kimbra Edwards | CISCRP | Julie Holtzople | PRE_DT08.pdf | |
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Day 3 Winter Data Transparency Event 2025 | N/A | REC_DT03.mp4 | |||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Medical imaging data sharing and de-identification, the BioData Catalyst® Data Management Core experience. | Zixin Nie | RTI International | PRE_DT09.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Ensuring Privacy with Meaningful Synthetic Data for RAVE EDC. | Jaskaran Singh Saini | Geninvo | PRE_DT10.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | AI in Action: Transforming Data Privacy and Compliance in the Pharmaceutical Industry. | Zach Weingarden | TrialAssure | PRE_DT11.pdf | ||
Data Transparency | 2025 | EU | Virtual – Winter Meeting | Content Analysis of Free-Text Patient Data in CSRs to Assess Automated Anonymisation Approaches. | Nastazja Laskowski | University of Manchester in collaboration with Roche | PRE_DT12.pdf | ||
Webinar | 2025 | Worldwide | Virtual | February Webinar Wednesday | WW | REC_WW02.mp4 | |||
Connect | 2024 | US | Bethesda | AR05: QTLs/Acceptable Ranges: How to Set Thresholds | Debra Jendrasek | Daiichi Sankyo | Marcus Muli | AR05; Analytics Risk-based Monitoring | PRE_AR05.pdf |
SDE | 2024 | US | Boston | RWD Quality – Driving Factor for Efficient Application of AI | Parag Shiralkar | Sumptuous Data Sciences | PRE_Boston05.pdf | ||
Connect | 2024 | EU | Strasbourg | AS03: A Tutorial for JFM Analysis in SAS for Modelling Recurrent Events and Death | Edyta Winciorek | Contractor at elderbrook solutions | AS03; Analytics & Statistics | PRE_AS03.pdfPAP_AS03.pdf |